The Israel Institute for Biological Research (IIBR) announced on Tuesday that it has completed “groundbreaking” research on an antibody that can potentially be used in treatments against the coronavirus (SARS-COV-2).
IIBR discovered that the specific antibody neutralizes the coronavirus after testing it against SARS-COV-2.
It is not a vaccine, but an antibody that they believe can be isolated and used to treat those already infected.
“Based on comprehensive scientific publications from around the globe, it appears that the IIBR is the first institution to achieve a scientific breakthrough that meets all three of the aforementioned parameters simultaneously. This is the result of the institute’s great experience and the unique capabilities of its scientists,” the Defense Ministry, which funds IIBR, said in a statement.
Read the rest of this story from our content partners at CBN News.
See an error in this article?
To contact us or to submit an article
